Showing results (181-190 of 228) with videos related to
Sort By:
Pageof 23
The Journal of Biological Chemistry|November 15, 1988
12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epitheliumR C Murphy, J R Falck, S Lumin, et al.Nitric Oxide : Biology and Chemistry|June 4, 2018
Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potentialE S Buys, D P Zimmer, J Chickering, et al.Prostaglandins|November 1, 1977
Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensionsP Needleman, B Bryan, A Wyche, et al.Science (New York, N.Y.)|March 1, 1985
Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areasC B Saper, D G Standaert, M G Currie, et al.The American Journal of Physiology|December 1, 1986
Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activityP Thorén, A L Mark, D A Morgan, et al.Biochemical Pharmacology|May 30, 1998
Identification and characterization of a novel delta6/delta5 fatty acid desaturase inhibitor as a potential anti-inflammatory agentM G Obukowicz, A Raz, P D Pyla, et al.Circulation Research|June 11, 1975
Development and maintenance of renal hypertension in normal and guanethidine sympathectomized ratsJ R Douglas, E M Johnson, G R Marshall, et al.Journal of Cardiovascular Pharmacology|November 1, 1985
Thromboxane A2 does not contribute to arrhythmogenesis during evolving canine myocardial infarctionJ B Kramer, A G Davis, R Dean, et al.Biochemical and Biophysical Research Communications|June 29, 1984
The sequence of an atriopeptigen: a precursor of the bioactive atrial peptidesD M Geller, M G Currie, N R Siegel, et al.The Journal of Comparative Neurology|August 15, 1992
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brainC D Breder, W L Smith, A Raz, et al.Pageof 23